China National Medicines Corp Ltd (600511) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.027x

Based on the latest financial reports, China National Medicines Corp Ltd (600511) has a cash flow conversion efficiency ratio of -0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-540.00 Million ≈ $-79.02 Million USD) by net assets (CN¥19.93 Billion ≈ $2.92 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See China National Medicines Corp Ltd balance sheet quality to measure how much of total assets are equity-financed.

China National Medicines Corp Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how China National Medicines Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of China National Medicines Corp Ltd to evaluate the quality of earnings relative to operating cash generation.

China National Medicines Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of China National Medicines Corp Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shufersal
TA:SAE
0.144x
COFCO Capital Holdings Co Ltd
SHE:002423
0.249x
Nicolet Bankshares Inc.
NYSE:NIC
0.007x
WIENERBERGER ADR 1/5/O.N.
F:WIBA
N/A
LG Display
KO:034220
0.078x
Jiangsu Changshu Rural Commercial Bank Co Ltd
SHG:601128
0.065x
Hayward Holdings Inc
NYSE:HAYW
-0.093x
Rev Group Inc
NYSE:REVG
0.185x

Annual Cash Flow Conversion Efficiency for China National Medicines Corp Ltd (2001–2024)

The table below shows the annual cash flow conversion efficiency of China National Medicines Corp Ltd from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see 600511 company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥18.98 Billion
≈ $2.78 Billion
CN¥1.66 Billion
≈ $242.78 Million
0.087x -43.78%
2023-12-31 CN¥17.53 Billion
≈ $2.57 Billion
CN¥2.73 Billion
≈ $399.00 Million
0.156x +2.97%
2022-12-31 CN¥15.86 Billion
≈ $2.32 Billion
CN¥2.40 Billion
≈ $350.48 Million
0.151x +10.76%
2021-12-31 CN¥14.36 Billion
≈ $2.10 Billion
CN¥1.96 Billion
≈ $286.44 Million
0.136x +37.17%
2020-12-31 CN¥13.09 Billion
≈ $1.92 Billion
CN¥1.30 Billion
≈ $190.48 Million
0.099x -31.95%
2019-12-31 CN¥12.16 Billion
≈ $1.78 Billion
CN¥1.78 Billion
≈ $259.89 Million
0.146x +57.88%
2018-12-31 CN¥10.61 Billion
≈ $1.55 Billion
CN¥981.65 Million
≈ $143.65 Million
0.093x -18.57%
2017-12-31 CN¥9.46 Billion
≈ $1.38 Billion
CN¥1.07 Billion
≈ $157.23 Million
0.114x -22.81%
2016-12-31 CN¥4.02 Billion
≈ $587.79 Million
CN¥591.25 Million
≈ $86.52 Million
0.147x +17.49%
2015-12-31 CN¥3.51 Billion
≈ $514.25 Million
CN¥440.29 Million
≈ $64.43 Million
0.125x +47.68%
2014-12-31 CN¥2.58 Billion
≈ $377.65 Million
CN¥218.94 Million
≈ $32.04 Million
0.085x +0.39%
2013-12-31 CN¥2.20 Billion
≈ $321.31 Million
CN¥185.56 Million
≈ $27.15 Million
0.085x -15.00%
2012-12-31 CN¥1.87 Billion
≈ $273.56 Million
CN¥185.87 Million
≈ $27.20 Million
0.099x +141.13%
2011-12-31 CN¥1.53 Billion
≈ $224.31 Million
CN¥-370.56 Million
≈ $-54.22 Million
-0.242x -202.04%
2010-12-31 CN¥1.34 Billion
≈ $196.55 Million
CN¥318.21 Million
≈ $46.56 Million
0.237x +0.56%
2009-12-31 CN¥1.08 Billion
≈ $158.49 Million
CN¥255.18 Million
≈ $37.34 Million
0.236x -5.77%
2008-12-31 CN¥868.25 Million
≈ $127.05 Million
CN¥217.10 Million
≈ $31.77 Million
0.250x +128.39%
2007-12-31 CN¥725.96 Million
≈ $106.23 Million
CN¥79.48 Million
≈ $11.63 Million
0.109x -46.75%
2006-12-31 CN¥590.99 Million
≈ $86.48 Million
CN¥121.50 Million
≈ $17.78 Million
0.206x +16.24%
2005-12-31 CN¥521.33 Million
≈ $76.29 Million
CN¥92.20 Million
≈ $13.49 Million
0.177x +75.64%
2004-12-31 CN¥488.38 Million
≈ $71.47 Million
CN¥49.18 Million
≈ $7.20 Million
0.101x +8868.91%
2003-12-31 CN¥468.65 Million
≈ $68.58 Million
CN¥526.15K
≈ $76.99K
0.001x -97.05%
2002-12-31 CN¥399.62 Million
≈ $58.48 Million
CN¥15.19 Million
≈ $2.22 Million
0.038x +143.44%
2001-12-31 CN¥134.77 Million
≈ $19.72 Million
CN¥-11.80 Million
≈ $-1.73 Million
-0.088x --

About China National Medicines Corp Ltd

SHG:600511 China Medical Distribution
Market Cap
$3.12 Billion
CN¥21.35 Billion CNY
Market Cap Rank
#4713 Global
#767 in China
Share Price
CN¥28.30
Change (1 day)
+0.64%
52-Week Range
CN¥25.70 - CN¥30.74
All Time High
CN¥57.66
About

China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental academic services, warehousing, logistics and import and export agency services. It also serves hospitals, re… Read more